Controversies in lung cancer screening

Journal of the American College of Radiology

Volumn 10, Issue 12, 2013, Pages 931-936

  Gill, Ritu R ^a   Jaklitsch, Michael T ^a   Jacobson, Francine L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CT scan; low dose CT; Lung cancer; lung cancer screening; overdiagnosis bias; tumor volume doubling time

Indexed keywords

ANTINEOPLASTIC AGENT;

ABLATION THERAPY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SIZE; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ERROR; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; RADIATION DOSE; RADIOLOGIST; SURVIVAL RATE; WORKFLOW; WORKLOAD;

CT SCAN; LOW-DOSE CT; LUNG CANCER; LUNG CANCER SCREENING; OVERDIAGNOSIS BIAS; TUMOR VOLUME DOUBLING TIME;

EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MASS SCREENING; PRIMARY PREVENTION; RADIOLOGY; UNITED STATES; UNNECESSARY PROCEDURES;

EID: 84889238793     PISSN: 15461440     EISSN: 1558349X     Source Type: Journal    
DOI: 10.1016/j.jacr.2013.09.013     Document Type: Article

References (52)

1. National Institute for Health and Clinical Excellence Lung cancer: the diagnosis and treatment of lung cancer. Clinical Guideline 24 2005 National Collaborating Centre for Acute Care London, United Kingdom
2. American Cancer Society. The American Cancer Society's estimates for lung cancer in the United States. http://www.cancer.org/cancer/lungcancer-non- smallcell/detailedguide/non-small-cell-lung-cancer-key-statistics. Accessed June 30, 2013.
3. The International Early Lung Cancer Action Program Investigators Survival of patients with stage 1 lung cancer detected on CT screening N Engl J Med 355 2006 1763 1771
4. C.I. Henschke, D.I. McCauley, and D.F. Yankelevitz Early Lung Cancer Action Project: a summary of the findings on baseline screening Oncologist 6 2001 147 152
5. C.I. Henschke Early lung cancer action project: overall design and findings from baseline screening Cancer 89 2000 2474 2482
6. L.L. Humphrey, M. Deffebach, and M. Pappas Screening for Lung cancer with low dose computed tomography: a systematic review to update the U.S. Preventive Services Task Force Recommendation Ann Intern Med 159 2013 411 420
7. The National Lung Screening Trial Team Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 2011 395 409
8. C. Henschke, D.E. McCauley, and D.F. Yankelevitz Early lung cancer action project: overall design and findings from baseline screening Lancet 354 1999 99 105
9. C.I. Henschke, D.P. Naidich, and D.F. Yankelevitz Early Lung Cancer Action Project: initial findings on repeat screenings Cancer 92 2001 153 159
10. D. Marshall, K.N. Simpson, C.C. Earle, and C.W. Chu Economic decision analysis model of screening for lung cancer Eur J Cancer 37 2001 1759 1767
11. D. Marshall, K.N. Simpson, C.C. Earle, and C. Chu Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort Lung Cancer 32 2001 227 236
12. T.N. Chirikos, T. Hazelton, M. Tockman, and R. Clark Cost-effectiveness of screening for lung cancer JAMA 289 2003 2358 2359
13. P.J. Mahadevia, L.A. Fleisher, K.D. Frick, J. Eng, S.N. Goodman, and N.R. Powe Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis JAMA 289 2003 313 322
14. M.M. Maher, M.K. Kalra, T.L. Toth, C. Wittram, S. Saini, and J. Shepard Application of rational practice and technical advances for optimizing radiation dose for chest CT J Thorac Imaging 19 2004 16 23
15. M. Gartenschlager, F. Schweden, and K. Gast Pulmonary nodules: detection with low-dose vs conventional-dose spiral CT Eur Radiol 8 1998 609 614
16. J. Burns, L.B. Haramati, K. Whitney, and M.N. Zelefsky Consistency of reporting basic characteristics of lung nodules and masses on computed tomography Acad Radiol 11 2004 233 237
17. S.G. Jennings, H.T. Winer-Muram, R.D. Tarver, and M.O. Farber Lung tumor growth: assessment with CT - comparison of diameter and cross-sectional area with volume measurements Radiology 231 2004 866 871
18. P.J. Nietert, J.G. Ravenel, and W.M. Leue Imprecision in automated volume measurements of pulmonary nodules and its effect on the level of uncertainty in volume doubling time estimation Chest 135 2009 1580 1587
19. M.P. Revel, A. Bissery, M. Bienvenu, L. Aycard, C. Lefort, and G. Frija Are two- dimensional CT measurements of small noncalcified pulmonary nodules reliable? Radiology 231 2004 453 458
20. K.P. Andriole, J.M. Wolfe, and R. Khorasani Optimizing analysis, visualization, and navigation of large image data sets: one 5000-section CT scan can ruin your whole day Radiology 259 2011 346 362
21. H. MacMahon, J.H. Austin, and G. Gamsu Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society Radiology 237 2005 395 400
22. American Association of Physicists in Medicine. AAPM response in regards to CT radiation dose and its effects. Available at: http://www.aapm.org/ publicgeneral/CTDoseResponse.asp. Accessed October 29, 2012.
23. R. Lacson, L.M. Prevedello, and K.P. Andriole Factors associated with radiologists' adherence to Fleischner Society guidelines for management of pulmonary nodules J Am Coll Radiol 9 2012 468 473
24. D.E. Ost, and M.K. Gould Decision making in patients with pulmonary nodules Am J Respir Crit Care Med 185 2012 363 372
25. P.B. Bach, G.A. Silvestri, M. Hanger, J.R. Jett American College of Chest Physicians Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 suppl 2007 69S 77S
26. M. Hiramatsu, T. Inagaki, and T. Inagaki Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth J Thorac Oncol 3 2008 1245 1250
27. D.P. Naidich, A.A. Bankier, and H. MacMahon Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society Radiology 266 2013 304 317
28. J.P. Wisnivesky, C.I. Henschke, and D.F. Yankelevitz Diagnostic percutaneous transthoracic needle biopsy does not affect survival in stage I lung cancer Am J Respir Crit Care Med 174 2006 684 688
29. R.R. Gill, S. Heon, and B.Y. Yeap Genomic profiling of non-small cell lung cancer (NSCLC) for personalized targeted therapy using CT-guided transthoracic needle biopsy (TTNB) J Clin Oncol 30 15 2012
30. J.R. Galvin, and T.J. Franks Lung cancer diagnosis: radiologic imaging, histology, and genetics Radiology 268 2013 9 11
31. C.I. Henschke, J.P. Wisnivesky, D.F. Yankelevitz, and O.S. Miettinen Small stage I cancers of the lung: genuineness and curability Lung Cancer 39 2003 327 330
32. M.M. Oken, W.G. Hocking, and P.A. Kvale Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) randomized trial JAMA 306 2011 1865 1873
33. T. Sobue, N. Moriyama, and M. Kaneko Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project J Clin Oncol 20 2002 911 920
34. P.M. Marcus, E.J. Bergstralh, and R.M. Fagerstrom Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up J Natl Cancer Inst 92 2000 1308 1316
35. Henschke CI. International Early Lung Cancer Action Program: enrollment and screening program. Available at: http://www.ielcap.org/professional/ protocols.html. Accessed June 30, 2013.
36. H.J. de Koning, R. Meza, and S.K. Plevritis Benefits and harms of computed tomography lung cancer screening programs for high-risk populations Lung Cancer 72 2011 322 326
37. J.P. van Meerbeeck Staging of non-small cell lung cancer: consensus, controversies and challenges Lung Cancer 34 suppl 2001 S95 S107
38. A.S. Wolf, W.G. Richards, and M.T. Jaklitsch Lobectomy versus sublobar resection for small (
39. J. Nyman, K.A. Johansson, and U. Hulten Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients Lung Cancer 51 2006 97 103
40. F.J. Lagerwaard, C.J. Haasbeek, E.F. Smit, B.J. Slotman, and S. Senan Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small cell lung cancer Int J Radiat Oncol Biol 70 2008 685 692
41. H.C. Fernando, A. De Hoyos, and R.J. Landreneau Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates J Thorac Cardiovasc Surg 129 2005 639 644
42. O.S. Breathnach, B. Freidlin, and B. Conley Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results J Clin Oncol 19 2001 1734 1742
43. T.J. Lynch, D.W. Bell, and R. Sordella Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 2004 2129 2139
44. J.G. Paez, P.A. Janne, and J.C. Lee EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500
45. W. Pao, V. Miller, and M. Zakowski EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with of tumors to gefitinib and erlotinib Proc Natl Acad Sci U S A 101 2004 13306 13311
46. F. Cappuzzo, F.R. Hirsch, and E. Rossi Epidermal growth factor receptor gene and protein and gefitinib in non-small-cell lung cancer J Natl Cancer Inst 97 2005 643 655
47. M.S. Tsao, A. Sakurada, and J.C. Cutz Erlotinib in lung cancer - molecular and clinical predictors of outcome N Engl J Med 353 2005 133 144
48. M.L. Bongers, V.M. Coupé, E.P. Jansma, E.F. Smit, and C.A. Uyl-de Groot Cost effectiveness of treatment with new agents in advanced non-small-cell lung cancer: a systematic review Pharmacoeconomics 30 2012 17 34
49. A.W. Castleberry, D. Smith, C. Anderson, A.J. Rotterand, and F.W. Grannis Jr. Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening Br J Cancer 101 2009 882 896
50. B.S. Pyenson, M.S. Sander, Y. Jiang, H. Kahn, and J.L. Mulshine An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost Health Aff (Millwood) 31 2012 770 779
51. P.M. McMahon, C.Y. Kong, and B.E. Johnson The MGH-HMS lung cancer policy model: tobacco control versus screening Risk Anal suppl 2012 S117 S124
52. D.R. Aberle, C.I. Henschke, T.C. McLoud, and P.M. Boiselle Expert opinion: barriers to CT screening for lung cancer J Thorac Imaging 27 2012 208